Rangeley Capital
$108M 13F equity value
203 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Rangeley Capital covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| DRVN | DRIVEN BRANDS HLDGS INC | 518,246 | $7M | 6.7% |
| RVMDW | REVOLUTION MEDICINES INC | 25,000 | $5M | 4.4% |
| PRTA | PROTHENA CORP PLC | 417,270 | $4M | 3.8% |
| SEG | SEAPORT ENTMT GROUP INC | 153,517 | $4M | 3.8% |
| GRND | GRINDR INC | 220,000 | $3M | 2.9% |
| STHO | STAR HLDGS | 324,408 | $3M | 2.8% |
| FLL | FULL HSE RESORTS INC | 925,578 | $3M | 2.4% |
| ABUS | ARBUTUS BIOPHARMA CORP | 500,000 | $2M | 2.2% |
| TRIP | TRIPADVISOR INC | 152,000 | $2M | 1.9% |
| ECHO | ECHOSTAR CORP | 17,800 | $2M | 1.7% |
Track Rangeley Capital's 13F portfolio: $108M in reported holdings, 203 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}